Vascular Growth Factor Inhibition with Bevacizumab Improves Cardiac Electrical Alterations and Fibrosis in Experimental Acute Chagas Disease

Vascular Growth Factor Inhibition with Bevacizumab Improves Cardiac Electrical Alterations and Fibrosis in Experimental Acute Chagas Disease

Chagas disease (CD) caused by <i>Trypanosoma cruzi</i> is a neglected illness and a major reason for cardiomyopathy in endemic areas. The existing therapy generally involves trypanocidal agents and therapies that control cardiac alterations. However, there is no treatment for the progres...

Full description

Bibliographic Details
Main Authors: Lindice Mitie Nisimura, Roberto Rodrigues Ferreira, Laura Lacerda Coelho, Gabriel Melo de Oliveira, Beatriz Matheus Gonzaga, Marcelo Meuser-Batista, Joseli Lannes-Vieira, Tania Araujo-Jorge, Luciana Ribeiro Garzoni
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Biology
Subjects:
angiogenesis
vascular endothelial growth factor
cardiac remodeling
Chagas disease
Online Access:https://www.mdpi.com/2079-7737/12/11/1414

Internet

https://www.mdpi.com/2079-7737/12/11/1414

Similar Items